These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8303157)

  • 21. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
    Remiche G; Kentos A; Mavroudakis N
    Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy".
    Berger AR; Herskovitz S; Kaplan J
    Muscle Nerve; 1995 Apr; 18(4):440-4. PubMed ID: 7715630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.
    Bril V; Katzberg H; Donofrio P; Banach M; Dalakas MC; Deng C; Hanna K; Hartung HP; Hughes RA; Latov N; Merkies IS; van Doorn PA;
    Muscle Nerve; 2009 Apr; 39(4):448-55. PubMed ID: 19260050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].
    Younes-Chennoufi AB; Baumann N
    Rev Neurol (Paris); 1996 May; 152(5):375-9. PubMed ID: 8881433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab therapy in monoclonal IgM-related neuropathies.
    Kilidireas C; Anagnostopoulos A; Karandreas N; Mouselimi L; Dimopoulos MA
    Leuk Lymphoma; 2006 May; 47(5):859-64. PubMed ID: 16753870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome.
    Engel WK
    Acta Myol; 2003 Dec; 22(3):97-103. PubMed ID: 15088499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
    Illa I; Rojas R; Gallardo E; Serrano C; Graus F
    Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraproteinemic neuropathies: foundations for a specific therapy related to patients' quality of life].
    Casadevall Codina T; Pérez Lázaro C; Santos S; Fabre Pi O; Garcés Redondo M; Larrodé Pellicer P
    Rev Neurol; 2004 Apr 1-15; 38(7):631-6. PubMed ID: 15098183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of intravenous immunoglobulin in neurological disorders].
    Steck AJ
    Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Dyck PJ; Low PA; Windebank AJ; Jaradeh SS; Gosselin S; Bourque P; Smith BE; Kratz KM; Karnes JL; Evans BA
    N Engl J Med; 1991 Nov; 325(21):1482-6. PubMed ID: 1658648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-glycoconjugate antibodies and dysglobulinemic or dysimmune peripheral neuropathies].
    Steck AJ; Kuntzer T
    Rev Neurol (Paris); 1996 May; 152(5):400-4. PubMed ID: 8881439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Availability of immune globulin intravenous for treatment of immune deficient patients--United States, 1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Mar; 48(8):159-62. PubMed ID: 10079062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lower motor neuron disease and signs of dysimmunity].
    Azulay JP; Attarian S; Boucraut J; Pouget J
    Rev Neurol (Paris); 2000 Apr; 156(4):372-9. PubMed ID: 10795014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
    Nobile-Orazio E; Manfredini E; Carpo M; Meucci N; Monaco S; Ferrari S; Bonetti B; Cavaletti G; Gemignani F; Durelli L
    Ann Neurol; 1994 Sep; 36(3):416-24. PubMed ID: 8080249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifocal motor neuropathy: response to human immune globulin.
    Chaudhry V; Corse AM; Cornblath DR; Kuncl RW; Drachman DB; Freimer ML; Miller RG; Griffin JW
    Ann Neurol; 1993 Mar; 33(3):237-42. PubMed ID: 8498806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurological manifestations of monoclonal gammopathies].
    Chassande B; Léger JM
    Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic relapsing multifocal sensory-motor neuropathy with conduction block.
    Sharoqi IA; Sadoh DR; Koutroumanidis M; Panayiotopoulos CP
    J Peripher Nerv Syst; 1998; 3(2):133-6. PubMed ID: 10959247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characterization and successful treatment of 6 patients with Churg-Strauss syndrome-associated neuropathy.
    Nakamura M; Yabe I; Yaguchi H; Kishimoto R; Mito Y; Fujiki N; Houzen H; Tsuji-Akimoto S; Niino M; Sasaki H
    Clin Neurol Neurosurg; 2009 Oct; 111(8):683-7. PubMed ID: 19647930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.